— Know what they know.
Not Investment Advice
Also trades as: 0EE0.L (LSE) · $vol 0M

QURE NASDAQ

uniQure N.V.
1W: -38.6% 1M: -49.2% 3M: -43.3% YTD: +0.3% 1Y: -57.3% 3Y: +240.0% 5Y: -30.5%
$23.46
+0.09 (+0.39%)
 
Weekly Expected Move ±19.6%
$14 $19 $23 $28 $33
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 29 · $1.6B mcap · 62M float · 3.45% daily turnover · Short 30% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$16M -40.6% ▼
5Y CAGR: -15.6%
Gross Profit
-$347K -103.9% ▼
Operating Income
-$185M -0.6% ▼
Net Income
-$199M +16.9% ▲
EPS (Diluted)
$-3.46 +29.7% ▲
EBITDA
-$179M -11.1% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$524M$106M$16M$27M$16M
YoY Growth+1296.8%-79.7%-85.1%+71.2%-40.6%
Cost of Revenue$25M$3M$14M$18M$16M
Gross Profit$499M$103M$2M$9M-$347K
Gross Margin95.2%96.9%14.0%32.4%-2.2%
R&D Expenses$144M$198M$215M$144M$134M
SG&A Expenses$56M$55M$73M$51M$51M
Operating Expenses$188M$246M$285M$193M$185M
Operating Income$311M-$143M-$283M-$184M-$185M
Operating Margin59.3%-134.4%-1785.5%-679.6%-1152.1%
Interest Expense$7M$12M$42M$64M$62M
Income Before Tax$333M-$128M-$307M-$237M-$193M
Tax Expense$3M-$1M$2M$2M$6M
Net Income$330M-$127M-$308M-$240M-$199M
Net Margin62.9%-119.1%-1947.1%-883.4%-1236.0%
EPS (Diluted)$7.04$-2.71$-6.47$-4.92$-3.46
EBITDA$319M-$108M-$253M-$161M-$179M
Shares Outstanding47M47M48M49M58M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms